A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756)

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(11 sites)

United States

University of Alabama, Birmingham, Alabama

Children's Hospital Colorado, Aurora, Colorado

Lurie Children's Hospital, Chicago, Illinois

Boston Children's Hospital, Boston, Massachusetts

Children's Minnesota, Saint Paul, Minnesota